Skip to main content Accessibility help
×
Home

Beyond ADHD and narcolepsy: psychostimulants in general psychiatry

  • Bradley Ng and Angela O'Brien

Summary

Psychostimulants (dexamphetamine, methylphenidate, modafinil) reduce fatigue, promote alertness and wakefulness, and have possible mood-enhancing properties. In modern psychiatric practice, their use has been limited to attention-deficit hyperactivity disorder and sleep disorders such as narcolepsy. Despite this, research has continued into psychostimulant use in general psychiatry, especially in the treatment of depression and fatigue. This article reviews the recent literature regarding psychostimulant use in general and consultation-liaison psychiatry. Although psychostimulants continue to attract clinical research, there is currently not enough evidence to recommend their routine use for general psychiatric conditions.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Beyond ADHD and narcolepsy: psychostimulants in general psychiatry
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Beyond ADHD and narcolepsy: psychostimulants in general psychiatry
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Beyond ADHD and narcolepsy: psychostimulants in general psychiatry
      Available formats
      ×

Copyright

Corresponding author

Bradley Ng, Older Persons Mental Health, Robina Hospital, Bayberry Lane, Robina, Queensland 4226, Australia. Email: bkwng@hotmail.com.

Footnotes

Hide All

Declaration of Interest

None.

Footnotes

References

Hide All
Alban, JP, Hopson, MM, Ly, V et al (2004) Effect of methylphenidate on vital signs and adverse effects in adults with traumatic brain injury. American Journal of Physical Medicine and Rehabilitation; 83: 131–7.
Berigan, T (2004) Modafinil treatment of excessive sedation associated with divalproex sodium. Canadian Journal of Psychiatry; 49: 72–3.
Block, SD (2000) Assessing and managing depression in the terminally ill patient. Annals of Internal Medicine; 132: 209–18.
Blockmans, D, Persoons, P, van Houdenhove, B et al (2006) Does methylphenidate reduce the symptoms of chronic fatigue syndrome? American Journal of Medicine; 119: 167.e23–30.
Breitbart, W, Rosenfeld, B, Kaim, M et al (2001) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Archives of Internal Medicine; 161: 411–20.
Bruera, E, Valero, V, Driver, L et al (2006) Patient-controlled methylphenidate for cancer fatigue. A double-blind, randomized, placebo-controlled trial. Journal of Clinical Oncology; 24: 2073–8.
Carlson, PJ, Merlock, MC, Suppes, T (2004) Adjunctive stimulant use in patients with bipolar disorder. Treatment of residual depression and sedation. Bipolar Disorders; 6: 416–20.
Challman, TD, Lipsky, JJ (2000) Methylphenidate. Its pharmacology and uses. Mayo Clinic Proceedings; 75: 711–21.
Chiarello, RJ, Cole, JO (1987) The use of psychostimulants in general psychiatry. A reconsideration. Archives of General Psychiatry; 44: 286–95.
Dackis, CA, Kampman, KM, Lynch, KG et al (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology; 30: 205–11.
DeBattista, C, Doghramji, K, Menza, MA et al (2003) Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder. A preliminary double-blind, placebo-controlled study. Journal of Clinical Psychiatry; 64: 1057–64.
Fava, M, Thase, ME, DeBattista, C (2005) A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. Journal of Clinical Psychiatry; 66: 8593.
Feinberg, SS (2004) Combining stimulants with monoamine oxidase inhibitors. A review of uses and one possible additional indication. Journal of Clinical Psychiatry; 65: 1520–4.
Fernandez, F, Levy, JK, Samley, HR et al (1995) Effects of methylphenidate in HIV-related depression. A comparative trial with desipramine. International Journal of Psychiatry in Medicine; 25: 5367.
Frierson, RL, Wey, JJ, Tabler, JB (1991) Psychostimulants for depression in the medically ill. American Family Physician; 43: 163–70.
Frye, MA, Grunze, H, Suppes, T et al (2007) A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. American Journal of Psychiatry; 164: 1242–9.
Galynker, I, Ieronimo, C, Miner, C et al (1997) Methylphenidate treatment of negative symptoms in patients with dementia. Journal of Neuropsychiatry and Clinical Neurosciences; 9: 231–9.
Grabowski, J, Roache, JD, Schmitz, JM et al (1997) Replacement medication for cocaine dependence. Methylphenidate. Journal of Clinical Psychopharmacology; 17: 485–8.
Grade, C, Redford, B, Chrostowski, J et al (1998) Methylphenidate in early post-stroke recovery. A double-blind, placebo-controlled study. Archives of Physical Medicine and Rehabilitation; 79: 1047–50.
Gualtieri, CT, Evans, RW (1988) Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Injury; 2: 273–90.
Gwirtsman, HE, Szuba, MP, Toren, L et al (1994) The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate. Psychopharmacology Bulletin; 30: 157–64.
Hinkin, CH, Castellon, SA, Hardy, DJ et al (2001) Methylphenidate improves HIV-1-associated cognitive slowing. Journal of Neuropsychiatry and Clinical Neurosciences; 13: 248–54.
Homsi, J, Walsh, D, Nelson, KA (2000) Psychostimulants in supportive care. Support Care in Cancer; 8: 385–97.
Jacobson, A (1958) The use of Ritalin in psychotherapy of depressions of the aged. Psychiatric Quarterly; 32: 474–83.
Jasinski, DR (2000) An evaluation of the abuse potential of modafinil using methylphenidate as a reference. Journal of Psychopharmacology; 14: 5360.
Kaelin, DL, Cifu, DX, Matthies, B (1996) Methylphenidate effect on attention deficit in the acutely brain-injured adult. Archives of Physical Medicine and Rehabilitation; 77: 69.
Kaplitz, SE (1975) Withdrawn, apathetic geriatric patients responsive to methylphenidate. Journal of the American Geriatrics Society; 23: 271–6.
Keating, GM, Raffin, MJ (2005) Modafinil. A review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs; 19: 785803.
Keen, JC, Brown, D (2004) Psychostimulants and delirium in patients receiving palliative care. Palliative & Supportive Care; 2: 199202.
Kraus, MF (1995) Neuropsychiatric sequelae of stroke and traumatic brain injury. The role of psychostimulants. International Journal of Psychiatry in Medicine; 25: 3951.
Lam, JY, Freeman, MK, Cates, ME (2007) Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Annals of Pharmacotherapy; 41: 1005–12.
Landman, ME, Peisig, R, Perlman, M (1958) A practical mood stimulant. Journal of the Medical Society of New Jersey; 55: 55–8.
Lavretsky, H, Park, S, Siddarth, P et al (2006) Methylphenidate-enhanced antidepressant response to citalopram in the elderly. A double-blind, placebo-controlled pilot trial. American Journal of Geriatric Psychiatry; 14: 181–5.
Lazarus, LW, Moberg, PJ, Langsley, PR et al (1994) Methylphenidate and nortriptyline in the treatment of poststroke depression. A retrospective comparison. Archives of Physical Medicine and Rehabilitation; 75: 403–6.
Lee, H, Kim, S-W, Kim, J-M et al (2005) Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Human Psychopharmacology; 20: 97104.
Martin, RT, Whyte, J (2007) The effects of methylphenidate on command following and yes/no communication in persons with severe disorders of consciousness. A meta-analysis of n-of-1 studies. American Journal of Physical Medicine and Rehabilitation; 86: 613–20.
Martinsson, L, Hårdemark, H-G, Eksborg, S (2007) Amphetamines for improving recovery after stroke. Cochrane Database of Systematic Reviews; issue 1: CD002090.
Masand, PS, Pickett, P, Murray, GB (1995) Hypomania precipitated by psychostimulant use in depressed medically ill patients. Psychosomatics; 36: 145–7.
Masand, PS, Tesar, GE (1996) Use of stimulants in the medically ill. Psychiatric Clinics of North America; 19: 516–47.
Masand, PS, Anand, VS, Tanquary, JF (1998) Psychostimulant augmentation of second generation antidepressants. A case series. Depression and Anxiety; 7: 8991.
Medicines and Healthcare products Regulatory Agency (2008) Modafinil: serious skin reactions, hypersensitivity, and psychiatric symptoms. Drug Safety Update; 1(8): 5.
Medicines and Healthcare products Regulatory Agency (2009) Methylphenidate: update guidance on safe and effective use in ADHD. Drug Safety Update; 2(8): 2.
Medsafe (2007) Dexamphetamine sulphate. Medsafe (http://www.medsafe.govt.nz/profs/datasheet/d/Dexamphetaminesulphatetab.htm).
Miller, SC (1996) Methylphenidate for clozapine sedation. American Journal of Psychiatry; 153: 1231–2.
Mooney, GF, Haas, LJ (1993) Effect of methylphenidate on brain injury-related anger. Archives of Physical Medicine and Rehabilitation; 74: 153–60.
Moore, DP (1981) Methylphenidate in depression and states of apathy. Southern Medical Journal; 74: 347–8.
Narendran, R, Young, CM, Valenti, AM et al (2002) Is psychosis exacerbated by modafinil? Archives of General Psychiatry; 59: 292–3.
Ninan, PT, Hassman, HA, Glass, SJ et al (2004) Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Journal of Clinical Psychiatry; 65: 414–20.
Nissen, SE (2006) ADHD drugs and cardiovascular risk. New England Journal of Medicine; 354: 1445–8.
Olson, LG, Ambrogetti, A, Sutherland, DC (2003) A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics; 44: 3843.
Orr, K, Taylor, D (2007) Psychostimulants in the treatment of depression. A review of the evidence. CNS Drugs; 21: 239–57.
Padala, PR, Burke, WJ, Bhatia, SC (2007) Modafinil therapy for apathy in an elderly patient. Annals of Pharmacotherapy; 41: 346–9.
Patkar, AA, Masand, PS, Pae, C–U et al (2006) A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Journal of Clinical Psychopharmacology; 26: 653–6.
Plenger, PM, Dixon, CE, Castillo, RM et al (1996) Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury. A preliminary double-blind placebo-controlled study. Archives of Physical Medicine and Rehabilitation; 77: 536–40.
Postolache, TT, Rosenthal, RN, Hellerstein, DJ et al (1999) Early augmentation of sertraline with methylphenidate. Journal of Clinical Psychiatry; 60: 123–4.
Rabkin, JG, McElhiney, MC, Rabkin, R et al (2004) Modafinil treatment for fatigue in HIV+ patients. A pilot study. Journal of Clinical Psychiatry; 65: 1688–95.
Randall, DC, Cafferty, FH, Shneerson, JM et al (2005) Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. Journal of Psychopharmacology; 19: 647–60.
Rosenthal, MH, Bryant, SL (2004) Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clinical Neuropharmacology; 27: 3843.
Rozans, M, Dreisbach, A, Lertora, JJL et al (2002) Palliative uses of methylphenidate in patients with cancer. A review. Journal of Clinical Oncology; 20: 335–9.
Satel, SL, Nelson, JC (1989) Stimulants in the treatment of depression. A critical overview. Journal of Clinical Psychiatry; 50: 241–9.
Schillerstrom, JE, Seaman, JS (2002) Modafinil augmentation of mirtazapine in a failure-to-thrive geriatric inpatient. International Journal of Psychiatry in Medicine; 32: 405–10.
Schwartz, TL, Leso, L, Beale, M et al (2002) Modafinil in the treatment of depression with severe comorbid medical illness. Psychosomatics; 43: 336–7.
Schwartz, TL, Azhar, N, Cole, K et al (2004) An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. Journal of Clinical Psychiatry; 65: 1223–7.
Sevy, S, Rosenthal, MH, Alvir, J et al (2005) Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. Journal of Clinical Psychiatry; 66: 839–43.
Sonde, L, Lökk, J (2007) Effects of amphetamine and/or L-dopa and physiotherapy after stroke. A blinded randomized study. Acta Neurologica Scandinavica; 115: 55–9.
Speech, TJ, Rao, SM, Osmon, DC et al (1993) A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Injury; 7: 333–8.
Wagner, GJ, Rabkin, R (2000) Effects of dextroamphetamine on depression and fatigue in men with HIV. A double-blind, placebo-controlled trial. Journal of Clinical Psychiatry; 61: 436–40.
Wallace, AE, Kofoed, LL, West, AN (1995) Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. American Journal of Psychiatry; 152: 929–31.
Whyte, J, Hart, T, Schuster, K et al (1997) Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. American Journal of Physical Medicine and Rehabilitation; 76: 440450.
Whyte, J, Vaccaro, M, Grieb-Neff, P et al (2002) Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. Journal of Head Trauma Rehabilitation; 17: 284–99.
Whyte, J, Hart, T, Vaccaro, M et al (2004) Effects of methylphenidate on attention deficits after traumatic brain injury. A multidimensional, randomized, controlled trial. American Journal of Physical Medicine and Rehabilitation; 83: 401–19.

Beyond ADHD and narcolepsy: psychostimulants in general psychiatry

  • Bradley Ng and Angela O'Brien

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Beyond ADHD and narcolepsy: psychostimulants in general psychiatry

  • Bradley Ng and Angela O'Brien
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *